Protecting May Morning Cushion 21 Powder
NDC Package 71217-0057-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Protecting May Morning Cushion 21 (citronellol, geraniol, linalool) powders is push the puff gently into the cushion and apply it from larger areas to smaller areasspread it evenly by lishtly patting onto the skin. This formulation utilizes a powder delivery system. Marketed by Inthismorning Co Ltd, this product is identified by NDC 71217-0057.

Identification & Billing

NDC Package Code
71217-0057-1
Package Description
13 g in 1 PACKAGE
Product Code
71217-0057
11-Digit Billing Format
71217005701

Clinical Specifications

Proprietary Name
Protecting May Morning Cushion 21
Non-Proprietary Name
Citronellol, Geraniol, Linalool
Substance Name
.beta.-citronellol, (r)-; Geraniol; Linalool, (+/-)-
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Push the puff gently into the cushion and apply it from larger areas to smaller areasspread it evenly by lishtly patting onto the skin

Regulatory & Marketing

Labeler Name
Inthismorning Co Ltd
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-15-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71217-0057-1 identifies a specific commercial package of 13 g in 1 package of Protecting May Morning Cushion 21, a human over the counter drug labeled by Inthismorning Co Ltd. This powder is formulated for topical use and contains .beta.-citronellol, (r)-; geraniol; linalool, (+/-)- as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Inthismorning Co Ltd on January 15, 2023. The current certification is valid through December 31, 2026.

How is this Inthismorning Co Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71217005701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
71217-0057-1
11-Digit CMS (5-4-2)
71217-0057-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.